menu
    • menu

    Find Insulin Lispro manufacturers, exporters & distributors on PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    13

    API Suppliers

    API Suppliers

    7

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    5

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    1

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    3

    API

    2

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    117

    FDF Dossiers

    FDF Dossiers

    3

    FDA Orange Book

    FDA (Orange Book)

    78

    Europe

    Europe

    16

    Canada

    Canada

    4

    Australia

    Australia

    15

    South Africa

    South Africa

    1

    Listed Dossiers

    Listed Dossiers

    9DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    1

    EDQM

    1

    USP

    3

    JP

    2

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    6

    Health Canada Patents

    DIGITAL CONTENT

    4

    Data Compilation #PharmaFlow

    1

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    73

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    481,306,410

    Annual Reports

    23,425

    Finished Drug Prices

    Listed Dossiers

    8 RELATED EXCIPIENT COMPANIES

    12EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 133107-64-9, Insulin lispro (5.97 mg), Insulin-lispro, Dtxsid90157956
    Molecular Formula
    C257H389N65O77S6
    Molecular Weight
    5814  g/mol
    InChI Key
    WNRQPCUGRUFHED-DETKDSODSA-N
    Insulin Lispro
    Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
    1 2D Structure

    Insulin Lispro

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-4-amino-1-[[(2S)-1-[[(2R)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-oxopentanoic acid;(4S)-4-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[(2S)-2-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
    2.1.2 InChI
    InChI=1S/C158H234N40O42S2.C99H155N25O35S4/c1-79(2)57-104(181-131(213)86(15)173-136(218)102(50-53-125(211)212)179-152(234)127(84(11)12)194-148(230)107(60-82(7)8)184-145(227)113(67-95-70-166-78-172-95)189-150(232)115(74-199)176-123(208)73-170-134(216)116(75-241)191-140(222)105(58-80(3)4)182-144(226)112(66-94-69-165-77-171-94)188-138(220)101(48-51-119(161)204)178-146(228)114(68-120(162)205)190-153(235)126(83(9)10)193-132(214)98(160)61-89-31-21-18-22-32-89)139(221)185-110(64-92-40-44-96(202)45-41-92)142(224)183-106(59-81(5)6)147(229)195-128(85(13)14)154(236)192-117(76-242)135(217)169-71-121(206)174-100(49-52-124(209)210)137(219)177-99(38-29-55-167-158(163)164)133(215)168-72-122(207)175-108(62-90-33-23-19-24-34-90)141(223)186-109(63-91-35-25-20-26-36-91)143(225)187-111(65-93-42-46-97(203)47-43-93)149(231)196-129(87(16)200)155(237)180-103(37-27-28-54-159)156(238)198-56-30-39-118(198)151(233)197-130(88(17)201)157(239)240;1-12-46(9)77(121-73(134)36-100)97(156)122-76(45(7)8)95(154)108-56(25-29-75(137)138)80(139)105-54(23-27-70(102)131)83(142)117-66(40-161)93(152)119-68(42-163)94(153)124-79(48(11)127)98(157)116-64(38-126)90(149)123-78(47(10)13-2)96(155)120-67(41-162)92(151)115-63(37-125)89(148)110-58(31-44(5)6)85(144)111-59(32-49-14-18-51(128)19-15-49)86(145)106-53(22-26-69(101)130)81(140)109-57(30-43(3)4)84(143)107-55(24-28-74(135)136)82(141)113-61(34-71(103)132)88(147)112-60(33-50-16-20-52(129)21-17-50)87(146)118-65(39-160)91(150)114-62(99(158)159)35-72(104)133/h18-26,31-36,40-47,69-70,77-88,98-118,126-130,199-203,241-242H,27-30,37-39,48-68,71-76,159-160H2,1-17H3,(H2,161,204)(H2,162,205)(H,165,171)(H,166,172)(H,168,215)(H,169,217)(H,170,216)(H,173,218)(H,174,206)(H,175,207)(H,176,208)(H,177,219)(H,178,228)(H,179,234)(H,180,237)(H,181,213)(H,182,226)(H,183,224)(H,184,227)(H,185,221)(H,186,223)(H,187,225)(H,188,220)(H,189,232)(H,190,235)(H,191,222)(H,192,236)(H,193,214)(H,194,230)(H,195,229)(H,196,231)(H,197,233)(H,209,210)(H,211,212)(H,239,240)(H4,163,164,167);14-21,43-48,53-68,76-79,125-129,160-163H,12-13,22-42,100H2,1-11H3,(H2,101,130)(H2,102,131)(H2,103,132)(H2,104,133)(H,105,139)(H,106,145)(H,107,143)(H,108,154)(H,109,140)(H,110,148)(H,111,144)(H,112,147)(H,113,141)(H,114,150)(H,115,151)(H,116,157)(H,117,142)(H,118,146)(H,119,152)(H,120,155)(H,121,134)(H,122,156)(H,123,149)(H,124,153)(H,135,136)(H,137,138)(H,158,159)/t86-,87+,88+,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,126-,127-,128-,129-,130-;46-,47-,48+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,76-,77-,78-,79-/m00/s1
    2.1.3 InChI Key
    WNRQPCUGRUFHED-DETKDSODSA-N
    2.1.4 Canonical SMILES
    CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)CN.CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CS)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC6=CN=CN6)NC(=O)C(CO)NC(=O)CNC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(CC7=CN=CN7)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC8=CC=CC=C8)N
    2.1.5 Isomeric SMILES
    CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN.C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC8=CC=CC=C8)N)O
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. 28(b)-lys-29(b)-pro-insulin

    2. 28(b)-lysine-29(b)-prolineinsulin

    3. Humalog

    4. Humalog Kwikpen

    5. Insulin, Lys(28b)-pro(29b)-

    6. Insulin, Lysyl(28b)-prolyl(28b)-

    7. Kwikpen, Humalog

    8. Lispro

    9. Lispro, Insulin

    10. Lyspro

    2.2.2 Depositor-Supplied Synonyms

    1. 133107-64-9

    2. Insulin Lispro (5.97 Mg)

    3. Insulin-lispro

    4. Dtxsid90157956

    2.3 Create Date
    2007-07-03
    3 Chemical and Physical Properties
    Molecular Weight 5814 g/mol
    Molecular Formula C257H389N65O77S6
    Hydrogen Bond Donor Count84
    Hydrogen Bond Acceptor Count89
    Rotatable Bond Count185
    Exact Mass5811.6913101 g/mol
    Monoisotopic Mass5809.6846004 g/mol
    Topological Polar Surface Area2310 Ų
    Heavy Atom Count405
    Formal Charge0
    Complexity13000
    Isotope Atom Count0
    Defined Atom Stereocenter Count52
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameHumalog
    PubMed HealthInsulin Lispro
    Drug ClassesAntidiabetic
    Drug LabelHumalog Mix50/50 [50% insulin lispro protamine suspension and 50% insulin lispro injection, (rDNA origin)] is a mixture of insulin lispro solution, a rapid-acting blood glucose-lowering agent and insulin lispro protamine suspension, an intermedi...
    Active IngredientInsulin lispro recombinant
    Dosage FormInjectable
    RouteInjection
    Strength100 units/ml
    Market StatusPrescription
    CompanyLilly

    2 of 2  
    Drug NameHumalog
    PubMed HealthInsulin Lispro
    Drug ClassesAntidiabetic
    Drug LabelHumalog Mix50/50 [50% insulin lispro protamine suspension and 50% insulin lispro injection, (rDNA origin)] is a mixture of insulin lispro solution, a rapid-acting blood glucose-lowering agent and insulin lispro protamine suspension, an intermedi...
    Active IngredientInsulin lispro recombinant
    Dosage FormInjectable
    RouteInjection
    Strength100 units/ml
    Market StatusPrescription
    CompanyLilly

    4.2 Drug Indication

    Insulin lispro is indicated to improve glycemic control in adults and children with diabetes mellitus.

    FDA Label

    Treatment of diabetes mellitus in adults.

    For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Insulin lispro Sanofi is also indicated for the initial stabilisation of diabetes mellitus.

    For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilisation of diabetes mellitus.

    For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilisation of diabetes mellitus.

    For the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilization of diabetes mellitus. Liprolog is a short acting insulin and may be used in conjunction with a longer acting human insulin. Liprolog is indicated for preprandial administration.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Insulin is a natural hormone produced by beta cells of the pancreas. In non-diabetic individuals, a basal level of insulin is supplemented with insulin spikes following meals. Increased insulin secretion following meals is responsible for the metabolic changes that occur as the body transitions from a postabsorptive to absorptive state. Insulin promotes cellular uptake of glucose, particularly in muscle and adipose tissues, promotes energy storage via glycogenesis, opposes catabolism of energy stores, increases DNA replication and protein synthesis by stimulating amino acid uptake by liver, muscle and adipose tissue, and modifies the activity of numerous enzymes involved in glycogen synthesis and glycolysis. Insulin also promotes growth and is required for the actions of growth hormone (e.g. protein synthesis, cell division, DNA synthesis). Insulin lispro is a rapid-acting insulin analogue used to mimic postprandial insulin spikes in diabetic individuals. The onset of action of insulin lispro is 10-15 minutes. Its activity peaks 60 minutes following subcutaneous injection and its duration of action is 4-5 hours. Compared to regular human insulin, insulin lispro has a more rapid onset of action and a shorter duration of action. Insulin lispro is also shown to be equipotent to human insulin on a molar basis.

    5.2 MeSH Pharmacological Classification

    Hypoglycemic Agents

    Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Pharmacological Classes
    Insulin [Chemical/Ingredient]; Insulin Analog [EPC]
    5.4 ATC Code

    A10AB04

    A10AB04

    A10AB04, A10AD04

    A10AB04, A10AD04

    A10AB04

    A - Alimentary tract and metabolism

    A10 - Drugs used in diabetes

    A10A - Insulins and analogues

    A10AB - Insulins and analogues for injection, fast-acting

    A10AB04 - Insulin lispro

    A - Alimentary tract and metabolism

    A10 - Drugs used in diabetes

    A10A - Insulins and analogues

    A10AC - Insulins and analogues for injection, intermediate-acting

    A10AC04 - Insulin lispro

    A - Alimentary tract and metabolism

    A10 - Drugs used in diabetes

    A10A - Insulins and analogues

    A10AD - Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting

    A10AD04 - Insulin lispro

    5.5 Absorption, Distribution and Excretion

    Absorption

    Insulin lispro is rapidly absorbed following subcutaneous administration. It is also absorbed more quickly than regular human insulin. Peak serum levels occur 30-90 minutes after injection in healthy subjects. Absorption also differs depending on the site of injection. After insulin lispro was administered in the abdomen, serum drug levels were higher and the duration of action was slightly shorter than after deltoid or thigh administration. The absolute bioavailability after subcutaneous injection ranges from 55% to 77% with doses between 0.1 to 0.2 unit/kg, inclusive. The mean observed area under the serum insulin concentration-time curve from time zero to infinity was 2360 pmol hr/L and 2390 pmol hr/L for HUMALOG U-200 and HUMALOG U-100, respectively. The corresponding mean peak serum insulin concentration was 795 pmol/L and 909 pmol/L for HUMALOG U-200 and HUMALOG U-100, respectively. The median time to maximum concentration was 1.0 hour for both formulations.

    Volume of Distribution

    When administered intravenously as bolus injections of 0.1 and 0.2 U/kg dose in two separate groups of healthy subjects, the mean volume of distribution of insulin lispro appeared to decrease with increase in dose (1.55 and 0.72 L/kg, respectively).

    Clearance

    Clearance is dose dependent. When a dose of 0.1 unit/kg and 0.2 unit/kg were administered intravenously, the mean clearance was 21.0 mL/min/kg and 9.6 mL/min/kg respectively.

    5.6 Metabolism/Metabolites

    Insulin is predominantly cleared by metabolic degradation via a receptor-mediated process.

    5.7 Biological Half-Life

    After subcutaneous administration of insulin lispro, the t1/2 is shorter than that of regular human insulin (1 versus 1.5 hours, respectively).

    5.8 Mechanism of Action

    Insulin lispro binds to the insulin receptor (IR), a heterotetrameric protein consisting of two extracellular alpha units and two transmembrane beta units. The binding of insulin to the alpha subunit of IR stimulates the tyrosine kinase activity intrinsic to the beta subunit of the receptor. The bound receptor autophosphorylates and phosphorylates numerous intracellular substrates such as insulin receptor substrates (IRS) proteins, Cbl, APS, Shc and Gab 1. Activation of these proteins leads to the activation of downstream signaling molecules including PI3 kinase and Akt. Akt regulates the activity of glucose transporter 4 (GLUT4) and protein kinase C (PKC), both of which play critical roles in metabolism and catabolism. In humans, insulin is stored in the form of hexamers; however, only insulin monomers are able to interact with IR. Reversal of the proline and lysine residues at positions B28 and B29 of native insulin eliminates hydrophobic interactions and weakens some of the hydrogen bonds that contribute to the stability of the insulin dimers that comprise insulin hexamers. Hexamers of insulin lispro are produced in the presence of zinc and m-cresol. These weakly associated hexamers quickly dissociate upon subcutaneous injection and are absorbed as monomers through vascular endothelial cells. These properties give insulin lispro its fast-acting properties.

    API SUPPLIERS

    read-more
    read-more

    01

    Sanofi

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4846

    Submission : 1983-03-11

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 23892

    Submission : 2010-06-07

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17123

    Submission : 2004-01-27

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27702

    Submission : 2013-11-28

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Biocon

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32125

    Submission : 2017-12-01

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Novo Nordisk

    Denmark

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5527

    Submission : 1984-09-14

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Novo Nordisk

    Denmark

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5533

    Submission : 1984-09-14

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Eli Lilly

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 217MF10534

    Registrant's Address : Lilly Corporate Center, Indianapolis, Indiana 46285, USA

    Initial Date of Registration : 2005-09-09

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Eli Lilly

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 219MF10053

    Registrant's Address : 65th Infantry Road, Km. 12.6, Carolina, Puerto Rico 00985

    Initial Date of Registration : 2007-03-05

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Wanbang Biopharmaceuticals

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Sanofi Aventis Deutschland Gmbh

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4846

    Submission : 1983-03-11

    Status : Inactive

    Type : II

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Biocon Ltd

    India

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    02

    Biocon Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27702

    Submission : 2013-11-28

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Medlab Asia & Asia Health
    Not Confirmed

    03

    Biocon Biologics India Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 23892

    Submission : 2010-06-07

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Medlab Asia & Asia Health
    Not Confirmed

    04

    Biocon Biologics India Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17123

    Submission : 2004-01-27

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Biocon Sdn Bhd

    India

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    05

    Biocon Sdn Bhd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32125

    Submission : 2017-12-01

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Novo Nordisk As

    Denmark

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    06

    Novo Nordisk As

    Denmark
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5527

    Submission : 1984-09-14

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Novo Nordisk As

    Denmark

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    07

    Novo Nordisk As

    Denmark
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5533

    Submission : 1984-09-14

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Lilly del Caribe, Inc.

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Lilly del Caribe, Inc.

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro (genetical recombination)

    Registration Number : 229MF10064

    Registrant's Address : 65th Infantry Road, Km. 12.6, Carolina, Puerto Rico 00985

    Initial Date of Registration : 2017-03-13

    Latest Date of Registration : 2017-12-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Lilly del Caribe, Inc.

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Lilly del Caribe, Inc.

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro (genetical recombination)

    Registration Number : 219MF10053

    Registrant's Address : 65th Infantry Road, Km. 12.6, Carolina, Puerto Rico 00985

    Initial Date of Registration : 2007-03-05

    Latest Date of Registration : 2017-12-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Lilly del Caribe, Inc.

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Lilly del Caribe, Inc.

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro (genetical recombination)

    Registration Number : 303MF10175

    Registrant's Address : 65th Infantry Road, Km. 12.6, Carolina, Puerto Rico 00985

    Initial Date of Registration : 2021-12-09

    Latest Date of Registration : 2021-12-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Eli Lilly and Company

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly and Company

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro (genetical recombination)

    Registration Number : 226MF10225

    Registrant's Address : Lilly Corporate Center, Indianapolis, Indiana 46285, USA

    Initial Date of Registration : 2014-12-08

    Latest Date of Registration : 2017-12-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Eli Lilly and Company

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly and Company

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro (genetical recombination)

    Registration Number : 217MF10534

    Registrant's Address : Lilly Corporate Center, Indianapolis, Indiana 46285, USA

    Initial Date of Registration : 2005-09-09

    Latest Date of Registration : 2017-12-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Wanbang Biopharmaceuticals

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Wanbang Biopharmaceuticals

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Insulin Lispro

    About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at t...

    Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    INSULIN LISPRO

    Brand Name : ADMELOG

    Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

    Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

    Packaging :

    Approval Date :

    Application Number : 209196

    Regulatory Info :

    Registration Country : USA

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    INSULIN LISPRO

    Brand Name : ADMELOG

    Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

    Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

    Packaging :

    Approval Date :

    Application Number : 209196

    Regulatory Info :

    Registration Country : USA

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Hood glass

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen, solo star

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Comb 25

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Sylinderampulle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Comb 25 OptiSet

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Rapid

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Hood glass

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Rapid OptiSet

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin lispro

    Brand Name : Insulin lispro Sanofi

    Dosage Form : Solution for injection in a pre-filled pen

    Dosage Strength : 100E/ml

    Packaging : Pre-filled pen 5 3ml

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Sanofi

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    INSULIN LISPRO

    Brand Name : ADMELOG

    Dosage Form : SOLUTION

    Dosage Strength : 100UNIT/ML

    Packaging : 3ML CARTRIDGE

    Approval Date :

    Application Number : 2469898

    Regulatory Info : Schedule D

    Registration Country : Canada

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    SANOFI-AVENTIS US

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    INSULIN LISPRO

    Brand Name : ADMELOG

    Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

    Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

    Approval Date :

    Application Number : 209196

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    SANOFI-AVENTIS US

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    INSULIN LISPRO

    Brand Name : ADMELOG SOLOSTAR

    Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

    Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

    Approval Date :

    Application Number : 209196

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SANOFI-AVENTIS US

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    INSULIN LISPRO

    Brand Name : ADMELOG

    Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

    Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

    Approval Date :

    Application Number : 209196

    RX/OTC/DISCN :

    RLD :

    TE Code :

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Europe

    read-more
    read-more

    01

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Hood glass

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Sylinderampulle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen, solo star

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Basal OptiSet

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Comb 25

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Sylinderampulle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Comb 25 OptiSet

    Dosage Form : Injection fluid, suspension

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Infusat

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Sylinderampulle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Rapid

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Hood glass

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Rapid

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Sylinderampulle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Sanofi-aventis Deutschland GmbH

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Insulin Lispro

    Brand Name : Insuman Rapid OptiSet

    Dosage Form : Injection fluid, resolution

    Dosage Strength : 100 IE/ml

    Packaging : Finish filled pen

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    South Africa

    read-more
    read-more

    01

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    75% Insulin Lispro Protamine Suspension (Npl)

    Brand Name : Humalog Mix25

    Dosage Form : PED

    Dosage Strength : 100iu/ml

    Packaging : 3X5iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    Insulin Lispro

    Brand Name : HUMALOG 200 units/ml KWIKPEN

    Dosage Form : INJ

    Dosage Strength : 200u/ml

    Packaging : 5X3u/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    Insulin Lispro

    Brand Name : Humalog

    Dosage Form : PED

    Dosage Strength : 100iu/ml

    Packaging : 3X5iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    75% Insulin Lispro Protamine Suspension (Npl)

    Brand Name : Humalog Mix 25

    Dosage Form : PED

    Dosage Strength : 100iu/ml

    Packaging : 3X5iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    Insulin Lispro

    Brand Name : HUMALOG 100 units/ml CARTRIDGE

    Dosage Form : CAT

    Dosage Strength : 100IU/ml

    Packaging : 3X5IU/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    Insulin Lispro

    Brand Name : Humalog

    Dosage Form : SUS

    Dosage Strength : 100iu/ml

    Packaging : 10X1iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    75% Insulin Lispro Protamine Suspension (Npl)

    Brand Name : Humalog Mix25

    Dosage Form : SUS

    Dosage Strength : 100iu/ml

    Packaging : 10X1iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Eli Lilly (SA) (Pty) Ltd

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    75% Insulin Lispro Protamine Suspension (Npl)

    Brand Name : Humalog Mix25

    Dosage Form : CAT

    Dosage Strength : 100iu/ml

    Packaging : 3X5iu/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Dezzo Trading 392 (Pty) Limited T/A Indo...

    South Africa
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Dezzo Trading 392 (Pty) Limited T/A Indo...

    South Africa
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Africa
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : South Africa

    Human Insulin

    Brand Name : Biosulin R

    Dosage Form : INJ

    Dosage Strength : 100iu/1ml

    Packaging : 5X1iu/1ml

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Dezzo Trading 392 (Pty) Limited T/A Indo...

    South Africa
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Dezzo Trading 392 (Pty) Limited T/A Indo...

    South Africa
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Africa
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : South Africa

    Human Insulin

    Brand Name : Biosulin N

    Dosage Form : INJ

    Dosage Strength : 100iu/1ml

    Packaging : 5X1iu/1ml

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Dossiers

    read-more
    read-more

    01

    Wanbang Biopharmaceuticals

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Wanbang Biopharmaceuticals

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : China

    Insulin Lispro

    Brand Name :

    Dosage Form : Injection

    Dosage Strength : 300IU/3ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : China

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    01

    Wanbang Biopharmaceuticals

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Wanbang Biopharmaceuticals

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Insulin Lispro

    Dosage : Injection

    Dosage Strength : 300IU/3ML

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : China

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Parenteral

    read-more
    read-more

    Topical

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    STOCK RECAP #PipelineProspector

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Annual Reports

    read-more
    read-more

    01

    Brand Name : Admelog/Insulin Lispro

    France
    arrow
    CPHI Middle east
    Not Confirmed
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2019 Revenue in Millions : 273

    2018 Revenue in Millions : 101

    Growth (%) : 169

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Admelog/Insulin Lispro

    France
    arrow
    CPHI Middle east
    Not Confirmed
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2018 Revenue in Millions : 105

    2017 Revenue in Millions : 0

    Growth (%) : NA

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 2,626

    2019 Revenue in Millions : 2,821

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 2,453

    2020 Revenue in Millions : 2,626

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 2,061

    2021 Revenue in Millions : 2,453

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2023 Revenue in Millions : 1,663

    2022 Revenue in Millions : 2,061

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Humalog

    Insulin lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2015 Revenue in Millions : 2,785

    2014 Revenue in Millions : 2,842

    Growth (%) : 2%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Humalog

    Insulin lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2014 Revenue in Millions : 6.70%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2016 Revenue in Millions : 2,769

    2015 Revenue in Millions : 2,842

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Humalog

    Insulin Lispro

    arrow
    CPHI Middle east
    Not Confirmed

    Brand Name : Humalog

    U.S.A
    arrow
    CPHI Middle east
    Not Confirmed

    Eli Lilly

    Insulin Lispro

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2017 Revenue in Millions : 2,865

    2016 Revenue in Millions : 2,769

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Market Place

    Do you need sourcing support? Ask us

    FDF DOSSIERS

    read-more
    read-more
    Mexico.png
    Various Finished Dosage Formulations needed in Mexico [ENA13437]
    A company that offers comprehensive medical services, from equipping hospitals, providing maintenance to medical equipment and making tests for various diseases is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with GMP. 1. Sitagliptin (50 mg) + Metformin (850 mg) Tablets. The required pack size is 56 Tablets per box. 2. Recombinant Origin NPH Insulin (100 UI in 10 ml) Vials. 3. Recombinant Origin Rapid-Acting Human Insulin (100 UI in 10 ml) Vials. 4. Enoxaparin Sodium (60 mg) Prefilled Syringes with and without safety devices.
    26 Apr 2022

    Reply

    26 Apr 2022

    Reply text-arrow

    Reply Comment (5)

    26 Apr 2022

    VietNam.png
    Various Finished Dosage Formulations needed in Vietnam [ENA12477]
    A large pharmaceutical company based in India that deals in various segments such as gynecology, cardiovascular, diabetology, asthma, pediatric, CNS, GI and NSAIDs is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The Indian suppliers must support this enquiry with USFDA or EUGMP & European suppliers must support this enquiry with WHO GMP. The final market is South East Asian countries. 1. Cefuroxime (250 mg or 500 mg) Tablets 2. Human Insulin (100 IU/ ml) Injections  3. Milrinone (10 mg) Vials 4. Cefoperazone (1 g) + Sulbactam (1 g) Injections 5. Dexlansoprazole (30 mg & 60 mg) Tablets
    21 Jan 2022

    Reply

    21 Jan 2022

    Reply text-arrow

    Reply Comment (6)

    21 Jan 2022

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    Health Canada Patents

    read-more
    read-more

    01

    Gowling Lafleur Henderson LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling Lafleur Henderson LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    Insulin Lispro

    Brand Name : HUMALOG

    Patent Number : 2151560

    Filing Date : 1995-06-12

    Strength per Unit : 100 U / ml

    Dosage Form : Solution for Injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Gowling Lafleur Henderson LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling Lafleur Henderson LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2015-06-12

    Date Granted : 2003-02-11

    Insulin Lispro

    Brand Name : HUMALOG

    Patent Number : 2151564

    Filing Date : 1995-06-12

    Strength per Unit : 100 U / ml

    Dosage Form : Solution for Injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2015-06-12

    Date Granted : 2003-02-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Gowling Lafleur Henderson LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling Lafleur Henderson LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    Insulin Lispro

    Brand Name : HUMALOG

    Patent Number : 2151560

    Filing Date : 1995-06-12

    Strength per Unit : 100 U / ml

    Dosage Form : Solution for Injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Gowling Lafleur Henderson LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling Lafleur Henderson LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2015-06-12

    Date Granted : 2003-02-11

    Insulin Lispro

    Brand Name : HUMALOG

    Patent Number : 2151564

    Filing Date : 1995-06-12

    Strength per Unit : 100 U / ml

    Dosage Form : Solution for Injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2015-06-12

    Date Granted : 2003-02-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Gowling WLG (Canada) LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling WLG (Canada) LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    Insulin Lispro

    Brand Name : HUMALOG KWIKPEN?

    Patent Number : 2151560

    Filing Date : 1995-06-12

    Strength per Unit : 200 units / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2015-06-12

    Date Granted : 2000-05-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Gowling WLG (Canada) LLP

    Insulin Lispro
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Gowling WLG (Canada) LLP

    Canada
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Patent Expiration Date : 2018-06-11

    Date Granted : 2010-09-14

    Insulin Lispro

    Brand Name : HUMALOG KWIKPEN?

    Patent Number : 2295140

    Filing Date : 1998-06-11

    Strength per Unit : 200 units / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2018-06-11

    Date Granted : 2010-09-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search